Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
Moritz Reiterer(Cornell University), James C. Lo(Cornell University), Lunkun Ma(Cornell University), Monika M. Safford(Cornell University), Parag Goyal(Cornell University), Lucía Carrau(Icahn School of Medicine at Mount Sinai), David Redmond(Cornell University), Yaron Bram(Cornell University), Robert E. Schwartz(Autonomix Medical (United States)), Skyler Uhl(Icahn School of Medicine at Mount Sinai), Benjamin R. tenOever(New York University), Nicolás Gómez-Banoy(Memorial Sloan Kettering Cancer Center), Laura Alonso(Cornell University), Kristy A. Brown(Cornell University), Alpana P. Shukla(Cornell University), Alfonso Rubio‐Navarro(Cornell University), Priya Bhardwaj(Cornell University), Mangala Rajan(Cornell University), Phoebe Piloco(Cornell University), Edward J. Schenck(Cornell University), Evan Sholle, Jennifer D. Lau(Cornell University), Sean Houhgton(Cornell University), Vasuretha Chandar(Cornell University), Luis G. Gómez-Escobar(Cornell University), Sergio Alvarez-Mulett(Cornell University), Katherine Hoffman(Cornell University), Ankit Gilani(New York Medical College)
Cited by 202
Related Papers
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
|Diabetes Care|2007|1.5k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k